ArticleBreast cancer research and treatment2025

Ocular adverse events of perioperative adjuvant docetaxel vs paclitaxel for breast cancer: propensity-score overlap-weighted analysis.

Chikako Iwai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.